Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan

Accurate monitoring of chronic kidney disease (CKD) progression is essential for efficient disease management. Here Chen et al. identify five serum metabolites in patients with stage 1–5 CKD whose levels associate with disease progression, and find that 5-methoxytryptophan and its regulatory enzyme...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Dan-Qian Chen, Gang Cao, Hua Chen, Christos P. Argyopoulos, Hui Yu, Wei Su, Lin Chen, David C. Samuels, Shougang Zhuang, George P. Bayliss, Shilin Zhao, Xiao-Yong Yu, Nosratola D. Vaziri, Ming Wang, Dan Liu, Jia-Rong Mao, Shi-Xing Ma, Jin Zhao, Yuan Zhang, You-Quan Shang, Huining Kang, Fei Ye, Xiao-Hong Cheng, Xiang-Ri Li, Li Zhang, Mei-Xia Meng, Yan Guo, Ying-Yong Zhao
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2019
Materias:
Q
Acceso en línea:https://doaj.org/article/4a04997a433f49e4a807e4cf744638af
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:4a04997a433f49e4a807e4cf744638af
record_format dspace
spelling oai:doaj.org-article:4a04997a433f49e4a807e4cf744638af2021-12-02T15:35:33ZIdentification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan10.1038/s41467-019-09329-02041-1723https://doaj.org/article/4a04997a433f49e4a807e4cf744638af2019-04-01T00:00:00Zhttps://doi.org/10.1038/s41467-019-09329-0https://doaj.org/toc/2041-1723Accurate monitoring of chronic kidney disease (CKD) progression is essential for efficient disease management. Here Chen et al. identify five serum metabolites in patients with stage 1–5 CKD whose levels associate with disease progression, and find that 5-methoxytryptophan and its regulatory enzyme TPH-1 exert anti-fibrotic effects in mouse models of kidney injury.Dan-Qian ChenGang CaoHua ChenChristos P. ArgyopoulosHui YuWei SuLin ChenDavid C. SamuelsShougang ZhuangGeorge P. BaylissShilin ZhaoXiao-Yong YuNosratola D. VaziriMing WangDan LiuJia-Rong MaoShi-Xing MaJin ZhaoYuan ZhangYou-Quan ShangHuining KangFei YeXiao-Hong ChengXiang-Ri LiLi ZhangMei-Xia MengYan GuoYing-Yong ZhaoNature PortfolioarticleScienceQENNature Communications, Vol 10, Iss 1, Pp 1-15 (2019)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Dan-Qian Chen
Gang Cao
Hua Chen
Christos P. Argyopoulos
Hui Yu
Wei Su
Lin Chen
David C. Samuels
Shougang Zhuang
George P. Bayliss
Shilin Zhao
Xiao-Yong Yu
Nosratola D. Vaziri
Ming Wang
Dan Liu
Jia-Rong Mao
Shi-Xing Ma
Jin Zhao
Yuan Zhang
You-Quan Shang
Huining Kang
Fei Ye
Xiao-Hong Cheng
Xiang-Ri Li
Li Zhang
Mei-Xia Meng
Yan Guo
Ying-Yong Zhao
Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan
description Accurate monitoring of chronic kidney disease (CKD) progression is essential for efficient disease management. Here Chen et al. identify five serum metabolites in patients with stage 1–5 CKD whose levels associate with disease progression, and find that 5-methoxytryptophan and its regulatory enzyme TPH-1 exert anti-fibrotic effects in mouse models of kidney injury.
format article
author Dan-Qian Chen
Gang Cao
Hua Chen
Christos P. Argyopoulos
Hui Yu
Wei Su
Lin Chen
David C. Samuels
Shougang Zhuang
George P. Bayliss
Shilin Zhao
Xiao-Yong Yu
Nosratola D. Vaziri
Ming Wang
Dan Liu
Jia-Rong Mao
Shi-Xing Ma
Jin Zhao
Yuan Zhang
You-Quan Shang
Huining Kang
Fei Ye
Xiao-Hong Cheng
Xiang-Ri Li
Li Zhang
Mei-Xia Meng
Yan Guo
Ying-Yong Zhao
author_facet Dan-Qian Chen
Gang Cao
Hua Chen
Christos P. Argyopoulos
Hui Yu
Wei Su
Lin Chen
David C. Samuels
Shougang Zhuang
George P. Bayliss
Shilin Zhao
Xiao-Yong Yu
Nosratola D. Vaziri
Ming Wang
Dan Liu
Jia-Rong Mao
Shi-Xing Ma
Jin Zhao
Yuan Zhang
You-Quan Shang
Huining Kang
Fei Ye
Xiao-Hong Cheng
Xiang-Ri Li
Li Zhang
Mei-Xia Meng
Yan Guo
Ying-Yong Zhao
author_sort Dan-Qian Chen
title Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan
title_short Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan
title_full Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan
title_fullStr Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan
title_full_unstemmed Identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan
title_sort identification of serum metabolites associating with chronic kidney disease progression and anti-fibrotic effect of 5-methoxytryptophan
publisher Nature Portfolio
publishDate 2019
url https://doaj.org/article/4a04997a433f49e4a807e4cf744638af
work_keys_str_mv AT danqianchen identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT gangcao identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT huachen identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT christospargyopoulos identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT huiyu identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT weisu identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT linchen identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT davidcsamuels identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT shougangzhuang identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT georgepbayliss identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT shilinzhao identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT xiaoyongyu identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT nosratoladvaziri identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT mingwang identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT danliu identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT jiarongmao identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT shixingma identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT jinzhao identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT yuanzhang identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT youquanshang identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT huiningkang identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT feiye identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT xiaohongcheng identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT xiangrili identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT lizhang identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT meixiameng identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT yanguo identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
AT yingyongzhao identificationofserummetabolitesassociatingwithchronickidneydiseaseprogressionandantifibroticeffectof5methoxytryptophan
_version_ 1718386529456357376